PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 3 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 7.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,686 | +177.8% | 4,750,000 | +111.1% | 0.44% | +219.7% |
| Q1 2023 | $1,687 | -14.5% | 2,250,000 | 0.0% | 0.14% | -18.5% |
| Q4 2022 | $1,974 | -99.9% | 2,250,000 | 0.0% | 0.17% | +46.1% |
| Q3 2022 | $2,035,000 | +5.0% | 2,250,000 | 0.0% | 0.12% | -5.0% |
| Q2 2022 | $1,939,000 | -3.7% | 2,250,000 | 0.0% | 0.12% | +18.6% |
| Q1 2022 | $2,014,000 | -2.8% | 2,250,000 | 0.0% | 0.10% | -10.5% |
| Q4 2021 | $2,071,000 | +2.7% | 2,250,000 | 0.0% | 0.11% | -1.7% |
| Q3 2021 | $2,016,000 | +44.1% | 2,250,000 | +50.0% | 0.12% | +56.8% |
| Q2 2021 | $1,399,000 | +2.0% | 1,500,000 | 0.0% | 0.07% | -11.9% |
| Q1 2021 | $1,371,000 | +5.2% | 1,500,000 | 0.0% | 0.08% | -8.7% |
| Q4 2020 | $1,303,000 | -4.2% | 1,500,000 | -25.0% | 0.09% | +187.5% |
| Q2 2019 | $1,360,000 | – | 2,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 20,060,000 | $22,713,000 | 5.56% |
| SILVERBACK ASSET MANAGEMENT LLC | 7,707,000 | $6,912,000 | 0.94% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,615,000 | $31,948,000 | 0.74% |
| DeepCurrents Investment Group LLC | 12,521,000 | $11,079,000 | 0.34% |
| AGF Investments LLC | 4,000,000 | $3,502,000 | 0.29% |
| WATER ISLAND CAPITAL LLC | 2,250,000 | $2,014,000 | 0.10% |
| L & S Advisors Inc | 935,000 | $829,000 | 0.10% |
| Sculati Wealth Management, LLC | 200,000 | $177,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,192,000 | $2,816,000 | 0.06% |
| Teton Advisors, Inc. | 400,000 | $354,000 | 0.06% |